Rapid Dose Therapeutics Corp. (CSE:DOSE)
Canada · Delayed Price · Currency is CAD 0.1500
+0.0050 (3.45%)
Jan 20, 2026, 3:56 PM EST
Rapid Dose Therapeutics Market Cap
Rapid Dose Therapeutics has a market cap or net worth of CAD 19.69 million as of January 20, 2026. Its market cap has decreased by -43.23% in one year.
Market Cap
19.69M
Enterprise Value
25.02M
Revenue
2.63M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.15
Market Cap Chart
Since December 17, 2018, Rapid Dose Therapeutics's market cap has decreased from 63.77M to 19.69M, a decrease of -69.12%. That is a compound annual growth rate of -15.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 19, 2026 | 19.69M | 11.54% |
| Dec 31, 2025 | 17.65M | -37.53% |
| Dec 31, 2024 | 28.26M | 63.18% |
| Dec 29, 2023 | 17.32M | -67.57% |
| Dec 31, 2021 | 53.40M | 110.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 17, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Thiogenesis Therapeutics | 33.69M |
| Microbix Biosystems | 31.93M |
| Devonian Health Group | 31.53M |
| Resverlogix | 27.32M |
| Hemostemix | 19.53M |
| Lobe Sciences | 18.86M |
| PreveCeutical Medical | 14.95M |
| Innovotech | 13.52M |